Advances in the Treatment of IgA Nephropathy
A Q&A with Jonathan Barratt, Ph.D., FRCP.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers Urge Payers to Encourage, not Inhibit, Biosimilar Competition
2
Challenges & Solutions behind post-acute care models with OneHome's Noel Gilliam
3
DCIS Redefined: Circulating Tumor Cells Prove Early Dissemination and Challenge the 'Preinvasive' Label
4
COVID-19 may increase the risk of shingles for some, Japanese study finds
5
